Researchers uncover 48 new genetic variants associated with multiple sclerosis

Brings to 110 known risk factors and provides important insight into disease mechanism

2013-09-30

(Press-News.org) Scientists of the International Multiple Sclerosis Genetics Consortium (IMSGC) have identified an additional 48 genetic variants influencing the risk of developing multiple sclerosis. This work nearly doubles the number of known genetic risk factors and thereby provides additional key insights into the biology of this debilitating neurological condition. The genes implicated by the newly identified associations underline the central role played by the immune system in the development of multiple sclerosis and show substantial overlap with genes known to be involved in other autoimmune diseases.

Published online September 29 in the journal Nature Genetics, the study, "Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis," is the largest investigation of multiple sclerosis genetics to date. Led by the University of Miami Miller School of Medicine, this study relied upon an international team of 193 investigators from 84 research groups in 13 countries and was funded by more than 40 local and national agencies and foundations.

Multiple sclerosis (MS) is a chronic disabling neurological condition that affects over 2.5 million individuals worldwide. The disease results in patchy inflammation and damage to the central nervous system that causes problems with mobility, balance, sensation and cognition depending upon where the damage to the central nervous system occurs. Neurological symptoms are often intermittent in the early stages of the disease but tend to persist and progressively worsen with the passage of time for the majority of patients. The risk of developing multiple sclerosis is increased in those who have a family history of the disease. Research studies in twins and adopted individuals have shown that this increased risk is primarily the result of genetic risk factors.

The findings released in this study nearly double the number of confirmed susceptibility loci, underline the critical role played by the immune system in the development of multiple sclerosis, and highlight the marked similarities between the genetic architecture underlying susceptibility to this and the many other autoimmune diseases.

The present study takes advantage of custom designed technology known as ImmunoChip—a high-throughput genotyping array specifically designed to interrogate a targeted set of genetic variants linked to one or more autoimmune diseases. IMSGC researchers used the ImmunoChip platform to analyze the DNA from 29,300 individuals with multiple sclerosis and 50,794 unrelated healthy controls, making this the largest genetics study ever performed for multiple sclerosis. In addition to identifying 48 new susceptibility variants, the study also confirmed and further refined a similar number of previously identified genetic associations. With these new findings, there are now 110 genetic variants associated with MS. Although each of these variants individually confers only a very small risk of developing multiple sclerosis, collectively they explain approximately 20 percent of the genetic component of the disease.

Explaining the significance of the work and the nature of the collaboration, the Miller School's Jacob McCauley, Ph.D., who led the study on behalf of the IMSGC, said, "With the release of these new data, our ongoing effort to elucidate the genetic components of this complex disease has taken a major step forward. Describing the genetic underpinnings of any complex disease is a complicated but critical step. By further refining the genetic landscape of multiple sclerosis and identifying novel genetic associations, we are closer to being able to identify the cellular and molecular processes responsible for MS and therefore the specific biological targets for future drug treatment strategies. These results are the culmination of a thoroughly collaborative effort. A study of this size and impact is only possible because of the willingness of so many hard working researchers and thousands of patients to invest their time and energy in a shared goal."

### The International Multiple Sclerosis Genetics Consortium was founded in 2003 and today consists of multiple sclerosis and genetics researchers from around the world who coordinate their research activities in the belief that this is the shortest path to understanding the root causes of multiple sclerosis and using that understanding to bring about meaningful improvements for patients and those at risk of this debilitating disease.

Media contact: Lisa Worley
Executive Director of Medical Communications
University of Miami Miller School of Medicine
Tel: 1 (305) 243-5184
Email: Lworley2@med.miami.edu

ELSE PRESS RELEASES FROM THIS DATE:

Promising results for new antibody drug in non-small cell lung cancer patients: Smokers respond well

2013-09-30

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers. Presenting the most up-to-date data from 85 patients with non-small cell lung cancer in a large, phase I clinical trial of an experimental drug called MPDL3280A, Professor Jean-Charles Soria told the 2013 European Cancer Congress (ECC2013) [1] today (Sunday): "This is the first study to suggest a potential relationship between smoking history and response to inhibiting the ...

Identifying the disease-causing mechanisms in cancers with unknown primary site improves treatment

2013-09-30

Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear on Monday. In up to five percent of all cancers, the site of the primary tumour is unknown and the disease is not diagnosed until it is at an advanced stage, when the cancer has metastasised (spread to other parts of the body). Until recently, the choice of treatment has been based on efforts to find biomarkers that could indicate the site of origin, but now a team of researchers has succeeded in ...

Organized screening for prostate cancer does more harm than good

2013-09-30

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented on Monday by Professor Mathieu Boniol, at the 2013 European Cancer Congress (ECC2013) [1]. Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the Strathclyde Institute for Global Public Health at iPRI, Lyon, France, will ...

Leukemia cells are addicted to a healthy gene

2013-09-30

What keeps leukemia cells alive almost forever, able to continue dividing endlessly and aggressively? New research at the Weizmann Institute suggests that, in around a quarter of all leukemias, the cancer cells rely on an internal "balance of terror" to keep going. When one version of a certain gene is mutated, it becomes a cancer-promoting gene – an oncogene. But the new findings show that the second, normal version of the gene, which functions alongside the mutation, is what keeps the cells both cancerous and alive, able to continue forging their destructive pathway in ...

Eilat's corals stand better chance of resilience than other sites

2013-09-30

Jerusalem, Sept. 29, 2013 – Israel's southern Red Sea resort of Eilat, one of whose prime attractions is its colorful and multi-shaped underwater coral reefs, may have a clear advantage in the future over rival coral-viewing sites around the world, scientists at the Hebrew University of Jerusalem and Bar-Ilan University have found. Coral reefs, earth's richest and most diverse ecosystem, are deteriorating rapidly. One of the most devastating causes for that deterioration is coral bleaching, which typically occurs when seawater temperatures exceed the local summer maximum ...

New approaches to testing cancer drugs needed -- ESMO press commentary

2013-09-30

Lugano, Switzerland, 28th September -- Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, says the European Society for Medical Oncology. It has become clear in recent years that each patient's cancer has individual characteristics that are potentially amenable to "personalised" treatments that target those characteristics. But there is still a great deal of work to be done to ensure patients benefit ...

A review concerning relationships and independence of human number, time and space processing

2013-09-30

Perception of NTS are basic cognitive processes for humans to interact with their environment. Whether a common magnitude system exits for NTS processing is such an important question to investigate. Following and guided by previous researchers, Dr. Yalin Chen and Chang Liu, from the Laboratory of Cognitive Neuroscience and the School of Psychology, Nanjing Normal University, China, reviewed present evidence and provided some comments concerning this question. Their work, entitled "Relationships and independence of human number, time, and space processing", was published ...

Climate change: Fast out of the gate, slow to the finish the gate

2013-09-30

Washington, D.C.— A great deal of research has focused on the amount of global warming resulting from increased greenhouse gas concentrations. But there has been relatively little study of the pace of the change following these increases. A new study by Carnegie's Ken Caldeira and Nathan Myhrvold of Intellectual Ventures concludes that about half of the warming occurs within the first 10 years after an instantaneous step increase in atmospheric CO2 concentration, but about one-quarter of the warming occurs more than a century after the step increase. Their work is published ...

Young children recognize cigarette brands in developing countries with most smokers

2013-09-30

Nearly two-thirds of young children in low- and middle-income countries can identify cigarette brand logos, according to a study from researchers at the University of Maryland School of Public Health (UMD SPH) and the Johns Hopkins Bloomberg School of Public Health (JHSPH). The study, published in the journal Pediatrics, examined the reach of tobacco and cigarette marketing among some of the world's most vulnerable populations, sampling five and six year-old children from Brazil, China, India, Nigeria, Pakistan and Russia. These countries were selected because they have ...

Beyond the little blue pill: scientists develop compound that may treat priapism

2013-09-30

Bethesda, MD -- It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis. Specifically, a compound, called "C6'" offered mice -- with and without sickle cell disease -- relief by normalizing nitric oxide levels in penile blood. In addition ...

Researchers uncover 48 new genetic variants associated with multiple sclerosis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: